OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cost-Effectiveness of iGlarLixi Versus Premix BIAsp 30 in Patients with Type 2 Diabetes Suboptimally Controlled by Basal Insulin in the UK
Rory J. McCrimmon, Karen Palmer, Abdul Jabbar Omar Alsaleh, et al.
Diabetes Therapy (2022) Vol. 13, Iss. 6, pp. 1203-1214
Open Access | Times Cited: 5
Rory J. McCrimmon, Karen Palmer, Abdul Jabbar Omar Alsaleh, et al.
Diabetes Therapy (2022) Vol. 13, Iss. 6, pp. 1203-1214
Open Access | Times Cited: 5
Showing 5 citing articles:
Adverse drug events in cost-effectiveness models of pharmacological interventions for diabetes, diabetic retinopathy, and diabetic macular edema: a scoping review
Mari Pesonen, Virpi Jylhä, Eila Kankaanpää
JBI Evidence Synthesis (2024) Vol. 22, Iss. 11, pp. 2194-2266
Open Access | Times Cited: 2
Mari Pesonen, Virpi Jylhä, Eila Kankaanpää
JBI Evidence Synthesis (2024) Vol. 22, Iss. 11, pp. 2194-2266
Open Access | Times Cited: 2
Fixed-ratio combinations of basal insulin and glucagon-like peptide-1 receptor agonists as a promising strategy for treating diabetes
Hiroshi Nomoto
World Journal of Diabetes (2023) Vol. 14, Iss. 3, pp. 188-197
Open Access | Times Cited: 5
Hiroshi Nomoto
World Journal of Diabetes (2023) Vol. 14, Iss. 3, pp. 188-197
Open Access | Times Cited: 5
A Cost-effectiveness Analysis of iGlarLixi Versus IDegAsp and Appropriate Price Exploration of iGlarLixi for Type 2 Diabetes Mellitus Patients in China
Yanqing Jiang, Ruizhe Liu, Jianwei Xuan, et al.
Clinical Drug Investigation (2023) Vol. 43, Iss. 4, pp. 251-263
Closed Access | Times Cited: 3
Yanqing Jiang, Ruizhe Liu, Jianwei Xuan, et al.
Clinical Drug Investigation (2023) Vol. 43, Iss. 4, pp. 251-263
Closed Access | Times Cited: 3
Budget Impact Analysis of Intensification with iGlarLixi Compared to Alternative Treatment Strategies Among Patients with Type 2 Diabetes Mellitus
Jennifer Ken-Opurum, Sistla S. S. Srinivas, Divya Jain, et al.
Diabetes Therapy (2023) Vol. 14, Iss. 12, pp. 2109-2125
Open Access
Jennifer Ken-Opurum, Sistla S. S. Srinivas, Divya Jain, et al.
Diabetes Therapy (2023) Vol. 14, Iss. 12, pp. 2109-2125
Open Access
How Functional Premix Feed Be Used for Improvement of the Reproductive Capacity of Cattle
Leiyu Qu
Agricultural & Forestry Economics and Management (2022) Vol. 5, Iss. 1
Open Access
Leiyu Qu
Agricultural & Forestry Economics and Management (2022) Vol. 5, Iss. 1
Open Access
